Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
BIOX 
Bioceres Crop Solutions Corp (BIOX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: BIOX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -14.74% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 269.62M USD | Price to earnings Ratio 223 | 1Y Target Price 7.88 |
Price to earnings Ratio 223 | 1Y Target Price 7.88 | ||
Volume (30-day avg) 367140 | Beta 0.72 | 52 Weeks Range 3.69 - 13.18 | Updated Date 04/2/2025 |
52 Weeks Range 3.69 - 13.18 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.37% | Operating Margin (TTM) 7.08% |
Management Effectiveness
Return on Assets (TTM) 2.47% | Return on Equity (TTM) 0.62% |
Valuation
Trailing PE 223 | Forward PE 11.74 | Enterprise Value 524067776 | Price to Sales(TTM) 0.66 |
Enterprise Value 524067776 | Price to Sales(TTM) 0.66 | ||
Enterprise Value to Revenue 1.29 | Enterprise Value to EBITDA 11.73 | Shares Outstanding 60452800 | Shares Floating 32625318 |
Shares Outstanding 60452800 | Shares Floating 32625318 | ||
Percent Insiders 45.48 | Percent Institutions 20.68 |
Analyst Ratings
Rating 5 | Target Price 12.12 | Buy - | Strong Buy 4 |
Buy - | Strong Buy 4 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Bioceres Crop Solutions Corp
Company Overview
History and Background
Bioceres Crop Solutions Corp was founded in 2001. It initially focused on agricultural biotechnology and has evolved into a provider of crop productivity solutions, focusing on seeds and biologicals.
Core Business Areas
- Seed and Integrated Products: This segment focuses on the development and commercialization of seeds and seed traits, including HB4 drought tolerance technology for soybeans and wheat. It also includes seed treatments and other integrated products for enhanced crop yields.
- Biological Solutions: This segment develops and commercializes bio-insecticides, bio-fungicides, bio-nematicides, and bio-stimulants, offering sustainable alternatives to traditional agricultural chemicals. This includes inoculants.
- Crop Nutrition: This segment focuses on fertilizers and micronutrients to improve soil health and promote plant growth.
Leadership and Structure
The leadership team includes Federico Trucco (CEO) and Enrique Lopez Lecube (CFO). The company operates with a global structure, with operations and partnerships in various countries.
Top Products and Market Share
Key Offerings
- HB4 Technology: HB4 is Bioceres' proprietary drought tolerance technology for soybeans and wheat. It competes with traditional herbicide-tolerant traits and other drought-tolerance technologies. Market share data is variable and dependent on region, but adoption is growing in South America. Competitors include Bayer (MON), Corteva (CTVA), and Syngenta.
- Biological Insecticides: Bioceres offers a range of biological insecticides, including solutions based on Bacillus thuringiensis (Bt) strains. The biological insecticide market is growing rapidly, and Bioceres is gaining market share. Key competitors include Novozymes (now part of Novo Holdings A/S), Valent BioSciences, and Andermatt Biocontrol.
- Inoculants: Inoculants based on beneficial bacteria to improve nitrogen fixation and nutrient uptake in crops. Competitors include Novozymes (now part of Novo Holdings A/S), BASF, and Corteva (CTVA).
Market Dynamics
Industry Overview
The agricultural input industry is experiencing growth driven by increasing global demand for food, adoption of sustainable practices, and technological advancements in crop production. There is a growing focus on biological solutions and drought-tolerant crops.
Positioning
Bioceres is positioning itself as a leader in sustainable crop solutions, particularly in drought tolerance and biologicals. Its competitive advantage lies in its HB4 technology and its growing portfolio of biological products.
Total Addressable Market (TAM)
The total addressable market is estimated to be in the hundreds of billions of dollars, encompassing seeds, crop protection, and biologicals. Bioceres is targeting a significant portion of this market with its sustainable solutions, focusing on regions with high agricultural activity and drought risk.
Upturn SWOT Analysis
Strengths
- Proprietary HB4 technology
- Growing portfolio of biological solutions
- Strategic partnerships in key markets
- Strong presence in South America
Weaknesses
- Limited brand recognition compared to major players
- Reliance on regulatory approvals for HB4 adoption
- Geographic concentration in South America
- Variable profitability
Opportunities
- Expanding HB4 technology into new crops and regions
- Increasing demand for biological solutions
- Strategic acquisitions to expand product portfolio
- Partnerships with major agricultural companies
Threats
- Competition from established players with greater resources
- Regulatory hurdles and public perception of GMOs
- Adverse weather conditions impacting crop yields
- Fluctuations in commodity prices
Competitors and Market Share
Key Competitors
- BAYRY
- CTVA
- SYT
Competitive Landscape
Bioceres competes with larger, more established companies. Its advantages lie in its HB4 technology and its focus on sustainable solutions. Its disadvantages include limited brand recognition and financial resources.
Major Acquisitions
Pro Farm Technologies
- Year: 2019
- Acquisition Price (USD millions): 37.4
- Strategic Rationale: To expand its portfolio of biological crop nutrition products.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by the adoption of HB4 technology and the expansion of its biologicals portfolio. Growth rates have been variable.
Future Projections: Future growth is expected to be driven by continued expansion of HB4 adoption, increasing demand for biological solutions, and strategic partnerships. Analyst estimates vary.
Recent Initiatives: Recent initiatives include expanding HB4 soybean planting area, strategic acquisitions of biological companies, and collaborations with major agricultural players.
Summary
Bioceres Crop Solutions Corp is a growing agricultural company focused on sustainable solutions like HB4 technology and biological products. It has a strong presence in South America but faces competition from larger players. Success depends on the continued adoption of HB4, expansion of its biologicals portfolio, and successful partnerships. It needs to carefully manage regulatory hurdles and public perception.
Similar Companies
CTVA
Corteva Inc
CTVA
Corteva Inc
IPI
Intrepid Potash Inc
IPI
Intrepid Potash Inc
NTR
Nutrien Ltd
NTR
Nutrien Ltd
SYT
SYLA Technologies Co., Ltd. American Depositary Shares
SYT
SYLA Technologies Co., Ltd. American Depositary Shares
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is approximate and may vary by region. Financial data may be outdated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Bioceres Crop Solutions Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2018-03-22 | Executive Chairman & CEO Dr. Federico Trucco Ph.D. | ||
Sector Basic Materials | Industry Agricultural Inputs | Full time employees - | |
Full time employees - | |||
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.